 |
인쇄하기
취소
|
Choong-wae seeks 1 trillion won sales with new cancer treatment
Choong-wae Pharm announces that it will embark on phase I study of “CWP-231A”, a first-in-class candidate anticancer medicine targeting Wnt proteins.
The company said it will seek the approval of clinical studies by the U.S. Food and Drug Administration at the end of this month to develop the drug for acute myelogenous leukemia, multiple myeloma and lymphoma.
If a series of clinical trial...
The company said it will seek the approval of clinical studies by the U.S. Food and Drug Administration at the end of this month to develop the drug for acute myelogenous leukemia, multiple myeloma and lymphoma.
If a series of clinical trial...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.